Clinical Trials Browser

Phase 1/2 × Prostate-Specific Antigen × Genitourinary × Clear all

NCT02933255 2024-05-31

PROSTVAC in Combination With Nivolumab in Men With Prostate Cancer

Phase 1/2 Completed

24 enrolled 20 charts

Prostatic Neoplasms